where is the glp 1 receptor located GLP-1 Research Peptides: What Labs Need to Know GLP-1 Receptor Agonists as Treatments

The multivitamin question: are they enough

Foreman KJ, Marquez N, Dolgert A, et al

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down

Treatment with yttrium-90DOTA-[D-Phe1-Tyr3]-octreotide ( 90 Y-DOTATOC) decreased serum calcitonin levels as a primary endpoint, and survival benefits in responders were reported in a phase 2 trial of metastatic MTC [47]

They work through several important mechanisms: They increase insulin release from the pancreas when blood glucose is high They reduce excess glucose release from the liver They slow stomach emptying, helping prevent sharp glucose spikes after meals They increase feelings of fullness, often reducing appetite Because these effects depend on blood glucose levels, GLP-1 medications on their own carry a very low risk of causing low blood sugar (hypoglycaemia)

Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al